Ocular Therapeutix Inc (OCUL)
5.845
+0.82
(+16.20%)
USD |
NASDAQ |
May 02, 15:45
Ocular Therapeutix Gross Profit (TTM): 53.16M for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 53.16M |
September 30, 2023 | 52.81M |
June 30, 2023 | 50.00M |
March 31, 2023 | 47.23M |
December 31, 2022 | 46.95M |
September 30, 2022 | 45.09M |
June 30, 2022 | 45.04M |
March 31, 2022 | 44.55M |
December 31, 2021 | 39.12M |
September 30, 2021 | 34.58M |
June 30, 2021 | 29.17M |
March 31, 2021 | 19.98M |
December 31, 2020 | 15.32M |
September 30, 2020 | 10.07M |
June 30, 2020 | 4.665M |
March 31, 2020 | 3.328M |
December 31, 2019 | 1.902M |
September 30, 2019 | 0.872M |
June 30, 2019 | 1.232M |
Date | Value |
---|---|
March 31, 2019 | 1.629M |
December 31, 2018 | 1.525M |
September 30, 2018 | 1.512M |
June 30, 2018 | 1.527M |
March 31, 2018 | 1.366M |
December 31, 2017 | 1.466M |
September 30, 2017 | 1.476M |
June 30, 2017 | 1.443M |
March 31, 2017 | 1.445M |
December 31, 2016 | 1.444M |
September 30, 2016 | 1.404M |
June 30, 2016 | 1.377M |
March 31, 2016 | 1.42M |
December 31, 2015 | 1.431M |
September 30, 2015 | 1.562M |
June 30, 2015 | 1.335M |
March 31, 2015 | 1.033M |
December 31, 2014 | 0.681M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
0.872M
Minimum
Sep 2019
53.16M
Maximum
Dec 2023
28.69M
Average
34.58M
Median
Sep 2021
Gross Profit (TTM) Benchmarks
Amgen Inc | 19.74B |
Assertio Holdings Inc | 125.05M |
CytomX Therapeutics Inc | -- |
EyePoint Pharmaceuticals Inc | 41.39M |
Regeneron Pharmaceuticals Inc | 11.30B |